Good response. I have spoken to a number of people in the field...

First 4358 Last

Share
Profile

Follow
ajdm123

735 Posts.

89

07/05/21

19:40

Post #: 53028080
Share

Originally posted by phmurphy01: ↑

I’m always dubious when an ‘expert’ is approached anonymously and gives anonymous advice. But lets accept they have some credibility (out of interest is this person a hotcopper biotech commentator?)

firstly other posters have already posted NHMRC guidance which contradicts him:

.1.2. Generally, payment of participants should be limited to reimbursement of documented
expenses and remuneration for time and inconvenience in order to minimise the
likelihood of a payment acting as an undue influence (or undue inducement).In cases
where the research offers little or no benefit to individuals (e.g. early phase clinical trials)
or where the research requires the participation of target populations that are difficult
to recruit, payment may be offered as an incentive to participation, as long as adequate
processes are in place to promote valid consent.

secondly he states the trial involves procedures (s this referring to lymph gland biopsy?) as a result of the trial. My understanding is that this is part of the norlmal diagnostic process and not just required by the trial?

thirdly is he seriously advising that all the preparatory work in Australia is now forgotten, that management now find another company and start from scratch?

im far preferring the comments from other posters who have contacted the company and who have confirmed their awareness of the problem and the practical steps they are taking to deal with them

Expand

Good response. I have spoken to a number of people in the field and they have offered contrary opinions to this so called expert. I would think he is mistaken or confused. Incentives to come. Enrollments will happen.

IBX Price at posting: 8.0¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply